Abstract

This contract supports the advanced development of a novel antibacterial for the treatment of Gram-negative pathogens. The scope of work for this contract includes discovery, preclinical/non-clinical development activities, IND-enabling activities, and Phase I clinical trials.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
272200800042C-2-0-1
Application #
8441434
Study Section
Project Start
2008-09-01
Project End
2013-03-31
Budget Start
Budget End
Support Year
Fiscal Year
2012
Total Cost
$5,500,227
Indirect Cost

  Institution

Name
Trius Therapeutics, Inc.
Department
Type
DUNS #
171547339
City
San Diego
State
CA
Country
United States
Zip Code
92121